$ESTC

Morgan Stanley slashes targets on 3 software stocks after earnings

Morgan Stanley cut price targets on Elastic, UiPath and PagerDuty after their earnings, citing uneven AI impact across software. For Elastic, it kept Equal Weight and lowered the target to $73 from $80; Q4 remaining performance obligations rose 20% to $1.2B and RPO 27% to $1.98B. For UiPath, target fell to $15 from $17; FY2027 ARR guidance was $2.058B–$2.063B. PagerDuty target was cut to $7 from $10.

Original reporting
Published Jun 2, 2026, 5:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 6:20 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Morgan Stanley slashes targets on 3 software stocks after earnings — source image
Decision brief

The 30-second read

$ESTCNeutralMed
01

Why it matters

The key trading signal is the combination of (1) price target reductions and (2) explicit “AI momentum not yet in ARR” framing, which can drive near-term re-rating even when some operational metrics look better.

02

Market read

Analyst target cuts across three AI-adjacent software stocks highlight a market-wide preference for AI-to-ARR proof, not just AI adoption metrics.

03

What to watch

Elastic’s RPO/remaining performance obligations and UiPath’s net retention/customer mix improvements may eventually pull through to ARR; short-term target cuts may overreact to near-term guidance conservatism.

Relevance 9/10Novelty 6/10Timing: pre-market today (targets reset after earnings coverage)

Background

Morgan Stanley re-assessed three software names after their earnings, focusing on whether AI adoption is converting into durable revenue/ARR growth.

Company-level read

Ticker impact

$ESTCNeutralHigh confidence
Context

Morgan Stanley cut Elastic’s price target to $73 from $80 after earnings, citing strong bookings but FY2027 growth reacceleration assumptions.

Expected impact

Near-term pressure likely if investors focus on the lower target and “show-me” AI-to-revenue linkage.

Evidence & confidence

The article explicitly states the target cut and the rationale tied to guidance/ARR translation, which typically drives incremental repricing.

$PATHNeutralHigh confidence
Context

Morgan Stanley lowered UiPath’s price target to $15 from $17, saying AI momentum is improving but not yet showing up in recurring revenue growth.

Expected impact

Moderate downside risk/underperformance risk until ARR guidance or retention metrics accelerate.

Evidence & confidence

Target reduction is directly tied to lack of recurring revenue acceleration, a concrete driver for valuation.

$PDBearishHigh confidence
Context

Morgan Stanley maintained PagerDuty at Equal Weight and set a $7 price target vs. $10, citing flat ARR, retention softness, and seat compression.

Expected impact

Higher probability of continued multiple compression if ARR remains flat and retention trends don’t improve.

Evidence & confidence

The article provides specific negative operating/retention metrics and a lower price target, supporting a bearish near-term bias.

Market effects

Reinforces a software/AI valuation framework: bookings and AI deal activity are insufficient without evidence in deployed workloads and recognized/recurring revenue.

Primarily US-listed software sentiment; could spill into broader US software multiples via read-across on AI-to-ARR conversion.

Global AI software investors may tighten scrutiny on ARR conversion metrics, not just AI feature adoption or deal counts.

Counterpoint

Bookings and large AI deal growth could lead ARR acceleration later than the market expects; “show-me” may be timing-related rather than fundamental deterioration.

Key entities

  • Morgan Stanley

    Updated outlook and cut price targets on Elastic, UiPath, and PagerDuty after earnings.

  • Elastic N.V.

    Bookings and AI customer metrics improved, but Morgan Stanley cut the price target due to FY2027 growth reacceleration assumptions.

  • UiPath

    AI included in top deals and expansion deals grew, but recurring revenue acceleration remains the concern.

  • PagerDuty

    Profitability improved, yet ARR stability/retention and seat compression issues keep valuation capped.

Related articles

$PLTRHighAI 9/10

Palantir Rockets 16% After Q2 Blowout; C3.ai, UiPath Sit Out the Rally

Palantir Technologies reported Q2 2026 revenue of $1.94B, up 92.8% YoY, beating $1.81B consensus, and raised FY2026 revenue guidance to about $8.15B. U.S. commercial total contract value reached a record $2.1B. Shares rose about 16% to $145.50 after Deutsche Bank upgraded to Buy with a $200 target; C3.ai and UiPath did not rally.

$PLTRMed

JFrog, Zscaler, Palo Alto Networks, Shopify, and UiPath Shares Are Soaring, What You Need To Know

In Tuesday premarket trading, Palantir’s (PLTR) reported Q2 results and raised full-year revenue outlook drove a broad rally in enterprise software and cybersecurity peers. The article cites Palantir’s 26% jump and links the move to lower Treasury yields after geopolitical de-escalation. It also lists gains for JFrog (FROG), Zscaler (ZS), Palo Alto Networks (PANW), Shopify (SHOP), and UiPath (PATH).

$PATHMed

UiPath (NYSE:PATH) Shares Fall as Q2 Outlook Indicates Reduced ARR Growth

NEW YORK, July 30, 2026, 2:01 p.m. EDT — Shares of UiPath NYSE:PATH declined after the company forecasted slower additions to annualized recurring revenue for the second quarter. The stock dropped 3.3% to $12.18 in early U.S. trading. Initial estimates indicate Q2 guidance suggests net new ARR between $28 million and $33 million. Initial estimate: market value, adjusted for cash, is approximately 2.8 times the projected revenue for fiscal 2027. UiPath shares declined even as U.S.

$ZMMed

Stocks making big moves yesterday: Zoom, TransDigm, Elastic, Rocket Lab, and Tyson Foods

Stocks rose Monday on company or policy news. Zoom (ZM) gained 3.6% after opening API access to all customers, including trial accounts, and expanding Zapier integration. TransDigm (TDG) rose 4.1% on a deal to buy Prince & Izant for about $1.066B cash. Elastic (ESTC) up 5.2% on Jina On-Prem. Rocket Lab (RKLB) up 1.9% on a $266M U.S. Space Force launch contract. Tyson Foods (TSN) up 6.4% as USDA resumed cattle imports from Mexico amid Canadian tariff news.

$ESTCMed

Why Are Elastic (ESTC) Shares Soaring Today

Elastic (NYSE: ESTC) shares rose 5.2% intraday and closed at $61.21, up 3.6%, after the company launched Jina On-Prem to let customers run its Jina AI models in secure on-premises and air-gapped environments. The offering targets regulated industries needing data kept in-house. The article also notes prior Morgan Stanley downgrade and a 15.6% YTD decline.

$PATHMed

PATH Stock Slips As UBS Trims Price Target

UiPath (PATH) shares were up about 7.3% on AI automation optimism, but UBS cut its price target to $12 from $13 while keeping a Neutral rating. Street consensus remains Hold with a mean target near $13.47 versus a price around $10.81. The article also cites UiPath’s annual revenue of about $1.61B and recent quarterly net income of about $22.5M.